Healthcare Providers and Services
Company Overview of Bostwick Laboratories, Inc.
Bostwick Laboratories, Inc. provides anatomic and clinical pathology laboratory services specializing in the monitoring and diagnosis of cancer. It offers urologic and subspecialty laboratory services to hospitals; and services for rapid initial diagnoses of diseases and conditions. The company also provides practice solutions, such as online reporting, online requisitioning, and remote printing. In addition, it offers services in dermatology, gastroenterology, gynecology, nephrology, and hematology sectors of the anatomic pathology market. Further, the company provides pathology, tissue diagnosis, and support services for clinical trials and device studies in pharmaceutical and biotechnolog...
4355 Innslake Drive
Glen Allen, VA 23060
Founded in 1999
Key Executives for Bostwick Laboratories, Inc.
Chief Executive Officer of Aibiotech
Chief Compliance Officer and Vice President
Compensation as of Fiscal Year 2015.
Bostwick Laboratories, Inc. Key Developments
Bostwick Laboratories, Inc. to Pay United States $6,048,000 to Settle Allegations over Offering of Incentives to Physicians in Exchange for Referrals and Billed for Unordered Tests and Services
Oct 14 14
On behalf of its client Michael Daugherty, Morgan Verkamp, LLC announced that Bostwick Laboratories, Inc. has agreed to pay the United States $6,048,000 to resolve allegations regarding violations of the False Claims Act. The qui tam complaint was filed in May 2008. It alleges that Bostwick Laboratories improperly billed Medicare and Medicaid for tests and services referred in violation of the Anti-Kickback Statute and for tests performed without a doctor's order or consent. The Justice Department decided in June 2011 not to intervene in the case. In 2012, Senior District Judge S. Arthur Spiegel issued a well- reasoned order denying the defendants motions to dismiss. U.S. ex rel. Daugherty v. Bostwick Laboratories, et al., 2012 U.S. Dist. LEXIS 178641 (S.D. Ohio Dec. 18, 2012). The case against Bostwick Laboratories settled after the company entered into settlement discussions with Mr. Daugherty and the United States based on its inability to pay the full value of the damages sought in the qui tam action.
Metabolon, Inc. Signs Exclusive Multi-Year Marketing Agreement with Bostwick Laboratories
Oct 30 13
Metabolon, Inc. announced the signing of an exclusive multi-year Marketing Agreement with Bostwick Laboratories. Under the Agreement Bostwick will market Prostarix(TM), a non-invasive urine test for stratifying prostate cancer risk. The test will be offered for initial cancer evaluation to determine which men are candidates for prostate biopsy, and also for repeat biopsy decision-making for men with prior negative biopsies. Sample testing for Prostarix will be performed in Metabolon's CLIA-certified, CAP-accredited laboratory utilizing its mass spectroscopy-based analysis technology. The Agreement provides Metabolon with access to one of the large urology networks in the United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|